LLY

970.87

+2.45%↑

JNJ

221.5

+0.17%↑

ABBV

203.32

+1.08%↑

UNH

381.9

+0.65%↑

AZN

182.77

+0.25%↑

LLY

970.87

+2.45%↑

JNJ

221.5

+0.17%↑

ABBV

203.32

+1.08%↑

UNH

381.9

+0.65%↑

AZN

182.77

+0.25%↑

LLY

970.87

+2.45%↑

JNJ

221.5

+0.17%↑

ABBV

203.32

+1.08%↑

UNH

381.9

+0.65%↑

AZN

182.77

+0.25%↑

LLY

970.87

+2.45%↑

JNJ

221.5

+0.17%↑

ABBV

203.32

+1.08%↑

UNH

381.9

+0.65%↑

AZN

182.77

+0.25%↑

LLY

970.87

+2.45%↑

JNJ

221.5

+0.17%↑

ABBV

203.32

+1.08%↑

UNH

381.9

+0.65%↑

AZN

182.77

+0.25%↑

Home・Akciju saraksts・ResMed Inc

ResMed Inc

Atvērts

SektorsVeselības aprūpe

200.1 -3.14

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

199.2

Max

206.59

Galvenie mērījumi
By Trading Economics
Ienākumi	6.1M 399M
Pārdošana	8.6M 1.4B
P/E Sektora vidējais	19.758 49.8
EPS	2.86
Dividenžu ienesīgums	1.14
Peļņas marža	27.856
Darbinieki	10,600
EBITDA	-67M 500M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt
Prognoze 12 mēnešiem	+27.96% upside

Dividendes
By Dow Jones
Dividenžu ienesīgums Sektora vidējais	1.14% 2.25%
Nākamie ieņēmumi	2026. g. 30. jūl.
Nākamais dividenžu datums	2026. g. 18. jūn.
Nākamais Ex dividenžu datums	2026. g. 14. maijs

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-2B 30B
Iepriekšējā atvēršanas cena	203.24
Iepriekšējā slēgšanas cena	200.1

Ziņu noskaņojums

By Acuity

82%

18%

326 / 347 Rangs Healthcare

ResMed Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 10. maijs 23:47 UTC

Tirgus saruna

Gold Falls on Renewed Inflation Concerns -- Market Talk

2026. g. 10. maijs 23:44 UTC

Tirgus saruna

Nikkei May Rise on Signs of U.S. Economic Strength -- Market Talk

2026. g. 10. maijs 23:38 UTC

Tirgus saruna

Oil Rises Amid Signs of Ongoing Middle East Tensions -- Market Talk

2026. g. 10. maijs 23:14 UTC

Tirgus saruna

Australia's Political Map Continues to Be Redrawn -- Market Talk

2026. g. 10. maijs 22:22 UTC

Iegādes, apvienošanās, pārņemšana

Elevra Lithium: Expects Deal to Close in 1Q FY27

2026. g. 10. maijs 22:21 UTC

Iegādes, apvienošanās, pārņemšana

Elevra Lithium: Expects to Received About $71 Million Before Fees, Taxes in Cash

2026. g. 10. maijs 22:21 UTC

Iegādes, apvienošanās, pārņemšana

Elevra Lithium Agrees to Sell Ewoyaa Lithium Project Stake to Zhejiang Huayou Cobalt

2026. g. 10. maijs 10:21 UTC

Peļņas

Saudi Aramco Profit Jumps Despite War Disrupting Shipping Routes -- WSJ

2026. g. 9. maijs 06:05 UTC

Peļņas

Our Innodata Stock Pick Smashed Earnings Expectations. Stay Long. -- Barrons.com

2026. g. 8. maijs 23:55 UTC

Peļņas

Review & Preview: Still Going Strong -- Barrons.com

2026. g. 8. maijs 20:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 8. maijs 20:49 UTC

Peļņas

Why the Gap Between Chip and Software Stocks Keeps Getting Wider -- Barrons.com

2026. g. 8. maijs 20:25 UTC

Peļņas

These Stocks Are Today's Movers: Rocket Lab, Moderna, HubSpot, Nvidia, CoreWeave, Trade Desk, Cloudflare, Fluor, Akamai, IREN, and More -- Barrons.com

2026. g. 8. maijs 19:43 UTC

Peļņas

Cencosud 1Q Rev $4.565B >CENCOSUD.SN

2026. g. 8. maijs 19:43 UTC

Peļņas

Cencosud 1Q Net $115M

2026. g. 8. maijs 19:20 UTC

Tirgus saruna

Oil Futures End Session Higher, But Down on the Week -- Market Talk

2026. g. 8. maijs 19:18 UTC

Peļņas

Monster and Celsius Earnings Show Energy-Drink Fatigue Is Far From Over -- Barrons.com

2026. g. 8. maijs 19:16 UTC

Peļņas

This Mini Berkshire Hathaway Is a Buy. An Activist Investor Is Pushing to Break It Up. -- Barrons.com

2026. g. 8. maijs 19:08 UTC

Peļņas

This Mini Berkshire Hathaway Is a Buy. An Activist Investor Is Pushing to Break It Up. -- Barrons.com

2026. g. 8. maijs 19:05 UTC

Peļņas

Investors Feared Energy-Drink Fatigue. Monster and Celsius Earnings Offered Reassurance. -- Barrons.com

2026. g. 8. maijs 19:02 UTC

Tirgus saruna

U.S. Natural Gas Futures Little Changed on Week -- Market Talk

2026. g. 8. maijs 18:51 UTC

Peļņas

Memory Stocks Continue to Surge. What's Driving Micron and Sandisk Higher. -- Barrons.com

2026. g. 8. maijs 18:49 UTC

Peļņas

These Stocks Are Today's Movers: Rocket Lab, Moderna, HubSpot, Nvidia, CoreWeave, Trade Desk, Cloudflare, Fluor, Akamai, IREN, and More -- Barrons.com

2026. g. 8. maijs 18:41 UTC

Peļņas

McDonald's Stock Rises on Earnings Beat. The Value Push Needs to Maintain Momentum. -- Barrons.com

2026. g. 8. maijs 17:38 UTC

Tirgus saruna

U.S. Oil Rig Count Rises By 2 to 410 -- Market Talk

2026. g. 8. maijs 17:14 UTC

Peļņas

How High Gas Prices Need to Rise to Boost Electric Vehicle Sales -- Barrons.com

2026. g. 8. maijs 17:04 UTC

Tirgus saruna

Zcash Caps Off Parabolic Week -- Market Talk

2026. g. 8. maijs 16:20 UTC

Tirgus saruna

Tech, Media & Telecom Roundup: Market Talk

2026. g. 8. maijs 16:20 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 8. maijs 16:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

Salīdzinājums

Cenas izmaiņa

ResMed Inc Prognoze

Cenas mērķis

By TipRanks

27.96% augšup

Prognoze 12 mēnešiem

Vidējais 264.56 USD 27.96%

Augstākais 340 USD

Zemākais 225 USD

Pamatojoties uz 13 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi ResMed Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

13 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 13 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam ResMed Inc — pēdējo 3 mēnešu laikā.

Noskaņojums

By Acuity

326 / 347 Rangs Veselības aprūpe

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.